Clawing back: broadening the notion of metal chelators in medicine - Wikidata - wikimedia - TriplyDB

Clawing back: broadening the notion of metal chelators in medicine

Clawing back: broadening the notion of metal chelators in medicine

http://www.wikidata.org/entity/Q36791445

about

New β-lactamase inhibitors: a therapeutic renaissance in an MDR world.Comparison of various iron chelators and prochelators as protective agents against cardiomyocyte oxidative injury.Removal of Metabolic Liabilities Enables Development of Derivatives of Procaspase-Activating Compound 1 (PAC-1) with Improved Pharmacokinetics Metal complexes designed to bind to amyloid-β for the diagnosis and treatment of Alzheimer's disease.Ultraviolet light triggers the conversion of Cu2+-bound Aβ42 aggregates into cytotoxic species in a copper chelation-independent manner.New Delhi metallo-β-lactamase-1: structure, inhibitors and detection of producers.Developing drugs targeting transition metal homeostasis.Sirtuin inhibitor sirtinol is an intracellular iron chelator.Multi-target-directed phenol-triazole ligands as therapeutic agents for Alzheimer's disease.Stimulus-Responsive Prochelators for Manipulating Cellular Metals.Searching for harmony in transition-metal signaling.Zinc Complexes of Cyclodextrin-bearing 8-Hydroxyquinoline Ligands: A Comparative Study.Cu selective chelators relieve copper-induced oxidative stress

P2860

Q33622976-C87D9229-34ED-4C0A-964F-4C3B66C2791C Q34568034-B4E3E6D0-1E6C-4B09-84E2-F3029B6039A4 Q35598226-F4A3ADBF-5182-4D2F-8054-23A6C81CCFAA Q38199617-85A565FE-D609-45FD-AF17-7EE492513B1A Q38836859-FD82F6AE-98D7-4010-89BE-45F25CC09BB9 Q38851403-3CC0C478-CE7C-47F0-BA93-FF821CC3D5D9 Q39063848-4E1B3CF2-D0BD-4965-8897-40A79B51D743 Q41349934-E89279E1-1CBA-4E33-85AD-F1DA2B478CD6 Q42367176-7F959C33-14FD-4D44-BE06-5793993404E8 Q43285401-375D6067-B2B2-49AB-AA71-36541E61A671 Q46163158-9F8E2D14-F758-4B40-8D1D-2839F6FD5FF6 Q48214486-18B44E12-44CE-4DFB-8524-AA53A5DC13D6 Q59137566-FDAC78A4-2FFA-40A8-8106-C50F6F5B7846

P2860

Clawing back: broadening the notion of metal chelators in medicine

http://www.wikidata.org/entity/Q36791445

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Clawing back: broadening the notion of metal chelators in medicine

@ast

Clawing back: broadening the notion of metal chelators in medicine

@en

type

label

Clawing back: broadening the notion of metal chelators in medicine

@ast

Clawing back: broadening the notion of metal chelators in medicine

@en

prefLabel

Clawing back: broadening the notion of metal chelators in medicine

@ast

Clawing back: broadening the notion of metal chelators in medicine

@en

P1433

Q36791445-9C338D3C-B1DD-4F35-A5B2-779CB343DBB1

P1476

Q36791445-A6B06871-07D0-49BA-B264-3643FDCBC0B8

P2860

Q36791445-03E47622-26D8-4512-B715-483F530F8C7B

Q36791445-0C7E7DA3-302C-4609-B28D-6A432726C9F4

Q36791445-0DECD6F7-6D5D-4DEF-8EB6-07C144AC2F0E

Q36791445-1687F897-5F83-4052-9A5D-A924D436B5D1

Q36791445-1847C149-6DA9-4B0C-A516-568CBF74CB47

Q36791445-18E289BC-06FC-4A1F-99CD-7FCD08C30461

Q36791445-1F30A100-3B5A-47F3-8949-D35720E9EA75

Q36791445-21AAEE68-A24A-4F7C-85CF-956DD07F0EEC

Q36791445-22148EF5-153C-4572-B95E-E17C9490324D

Q36791445-35385B35-0237-4DC2-BC46-E231DA2D6559

P304

Q36791445-4B004A44-D926-49D1-88ED-14C8B2DCE904

P31

Q36791445-96F83923-C035-40BF-874A-4A2C2E95A4E8

P356

Q36791445-3B034A15-9C00-4E86-9CA0-600DDD95B9A8

P433

Q36791445-6F84812D-75EE-45C9-B447-206E2D44A24F

P478

Q36791445-C35734B7-0398-4B68-82D7-664140EED7CD

P50

Q36791445-9676C52A-A255-496C-8274-5C0F0004CA94

P577

Q36791445-90CBC09B-8F7D-4A43-8AE7-BFE3117F6017

P698

Q36791445-9BDDAECE-1D97-4B95-8233-1C6F0D2F409E

P932

Q36791445-00534454-3C70-44BC-BAC4-5F1447F74317

P356

J.CBPA.2012.12.021

P1433

Current Opinion in Chemical Biology

P1476

Clawing back: broadening the notion of metal chelators in medicine

@en

P2860

Why the NIH Trial to Assess Chelation Therapy (TACT) should be abandoned

Mercury, vaccines, and autism: one controversy, three histories

Pediatric fatality secondary to EDTA chelation

Mitochondrial electron transport is the cellular target of the oncology drug elesclomol

Identifying chelators for metalloprotein inhibitors using a fragment-based approach.

Minding metals: tailoring multifunctional chelating agents for neurodegenerative disease.

A prochelator activated by beta-secretase inhibits Abeta aggregation and suppresses copper-induced reactive oxygen species formation.

Chelation therapy for coronary heart disease: An overview of all clinical investigations.

Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice.

The story of penicillamine: a difficult birth.

P304

143-149

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CBPA.2012.12.021

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

Katherine J Franz

P577

2013-01-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23332666

http://www.w3.org/2001/XMLSchema#string

P932

3634900

http://www.w3.org/2001/XMLSchema#string